PMID- 31347748 OWN - NLM STAT- MEDLINE DCOM- 20191025 LR - 20210618 IS - 1365-2184 (Electronic) IS - 0960-7722 (Print) IS - 0960-7722 (Linking) VI - 52 IP - 5 DP - 2019 Sep TI - Caspase-3-mediated GSDME activation contributes to cisplatin- and doxorubicin-induced secondary necrosis in mouse macrophages. PG - e12663 LID - 10.1111/cpr.12663 [doi] LID - e12663 AB - OBJECTIVE: Induction of secondary necrosis/pyroptosis contributes to the toxicity of chemotherapeutic drugs, in which gasdermin E (GSDME) plays critical roles. This study aimed to explore whether GSDME is involved in mediating the cytotoxic effects of cisplatin and doxorubicin on mouse macrophages. METHODS: RAW 264.7 cells and bone marrow-derived macrophages (BMDMs) were treated with cisplatin or doxorubicin. Propidium iodide staining was used to assay necrosis, and immunoblotting was performed to detect protein expression. GSDME was knocked down by using small interfering RNA. Mice were injected intraperitoneally to evaluate toxicity to macrophages in vivo. Flow cytometry and immunofluorescence microscopy were adopted to analyse phenotypes of peritoneal cells. Cytokine levels were assayed by cytometric bead array. RESULTS: Both cisplatin and doxorubicin dose-dependently induced necrosis in mouse RAW 264.7 macrophages and BMDMs. Accompanying this, multiple caspases were activated, concomitant with the cleavage of poly (ADP-ribose) polymerase. Consistent with caspase-3 activation, GSDME was cleaved to generate its N-terminal fragment (GSDME-NT), thus leading to secondary necrosis/pyroptosis. Inhibition of caspase-3 significantly attenuated the generation of GSDME-NT concurrently with decreased necrosis in macrophages. GSDME knockdown also evidently decreased the necrosis in RAW 264.7 and BMDMs. Besides, cisplatin administration depleted peritoneal macrophages in mice, which was associated with caspase-3 activation and GSDME-NT generation. Consistent with the macrophage depletion, cisplatin administration significantly decreased survival of mice with bacterial infection. CONCLUSION: Chemotherapeutic cisplatin and doxorubicin exerted their cytotoxicity on macrophages partly by inducing caspase-3/GSDME-mediated secondary necrosis. CI - (c) 2019 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd. FAU - Mai, Feng-Yi AU - Mai FY AD - Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - He, Pengyan AU - He P AD - School of Medicine, Sun Yat-Sen University, Shenzhen, China. FAU - Ye, Jie-Zhou AU - Ye JZ AD - Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - Xu, Li-Hui AU - Xu LH AD - Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - Ouyang, Dong-Yun AU - Ouyang DY AD - Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - Li, Chen-Guang AU - Li CG AD - Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - Zeng, Qiong-Zhen AU - Zeng QZ AD - Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - Zeng, Chen-Ying AU - Zeng CY AD - Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - Zhang, Cheng-Cheng AU - Zhang CC AD - Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - He, Xian-Hui AU - He XH AUID- ORCID: 0000-0001-7433-7392 AD - Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. FAU - Hu, Bo AU - Hu B AD - Department of Nephrology, the First Affiliated Hospital of Jinan University, Guangzhou, China. LA - eng GR - 81673664/National Natural Science Foundation of China/ GR - 81773965/National Natural Science Foundation of China/ GR - 81873064/National Natural Science Foundation of China/ PT - Journal Article DEP - 20190726 PL - England TA - Cell Prolif JT - Cell proliferation JID - 9105195 RN - 0 (Cytokines) RN - 0 (Gsdme protein, mouse) RN - 0 (RNA, Small Interfering) RN - 0 (Receptors, Estrogen) RN - 80168379AG (Doxorubicin) RN - EC 3.4.22.- (Caspase 3) RN - Q20Q21Q62J (Cisplatin) SB - IM MH - Animals MH - Apoptosis/drug effects MH - Caspase 3/*metabolism MH - Cisplatin/*pharmacology MH - Cytokines/metabolism MH - Doxorubicin/*pharmacology MH - Escherichia coli Infections/drug therapy/mortality/pathology/veterinary MH - Macrophages/cytology/drug effects/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Pyroptosis/*drug effects MH - RAW 264.7 Cells MH - RNA Interference MH - RNA, Small Interfering/metabolism MH - Receptors, Estrogen/antagonists & inhibitors/genetics/*metabolism MH - Survival Rate PMC - PMC6797504 OTO - NOTNLM OT - caspase-3 OT - chemotherapeutic drugs OT - gasdermin E OT - macrophages OT - secondary necrosis COIS- The authors have no conflicts of interest to declare. EDAT- 2019/07/28 06:00 MHDA- 2019/10/28 06:00 PMCR- 2019/07/26 CRDT- 2019/07/27 06:00 PHST- 2019/01/29 00:00 [received] PHST- 2019/06/01 00:00 [revised] PHST- 2019/06/27 00:00 [accepted] PHST- 2019/07/28 06:00 [pubmed] PHST- 2019/10/28 06:00 [medline] PHST- 2019/07/27 06:00 [entrez] PHST- 2019/07/26 00:00 [pmc-release] AID - CPR12663 [pii] AID - 10.1111/cpr.12663 [doi] PST - ppublish SO - Cell Prolif. 2019 Sep;52(5):e12663. doi: 10.1111/cpr.12663. Epub 2019 Jul 26.